Static Chart BioXcel Therapeutics, Inc.

Equities

Market Closed - Nasdaq Other stock markets 16:00:00 2025-01-10 EST			5-day change	1st Jan Change
0.3773 ^USD	-2.13%		-8.86%	+0.91%

01-07	BofA Securities Downgrades BioXcel Therapeutics to Underperform From Buy, Adjusts Price Target to $0.25 From $7	MT
11-21	Bioxcel Therapeutics, Inc. Appoints David Mack to the Board, Compensation Committee and Capital Raising Committee	CI

Duration

Period